| |
| |
|
| Insider
Information: |
Castellanos Elaine |
| Relationship: |
VP, Chief Accounting O... |
| City: |
Irving |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
14,546 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,507,149 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
14,546 |
|
|
| Total
Value |
$2,507,149 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -239.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Reata Pharmaceuticals Inc |
RETA |
VP, Chief Accounting O... |
2021-06-09 |
14,546 |
2016-06-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RETA |
Reata Pharmaceuticals Inc |
VP, Chief Accounting Officer |
• – – |
2021-06-09 |
4 |
S |
$141.86 |
$1,199,630 |
D/D |
(8,454) |
14,546 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
VP, Chief Accounting Officer |
• – – |
2021-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
8,454 |
23,000 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
VP, Chief Accounting Officer |
• – – |
2021-06-07 |
4 |
S |
$146.47 |
$226,883 |
D/D |
(1,546) |
14,546 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
VP, Chief Accounting Officer |
• – – |
2021-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,546 |
16,092 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
VP, Chief Accounting Officer |
• – – |
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
24,546 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
VP, Chief Accounting Officer |
• – – |
2021-05-26 |
4 |
S |
$124.55 |
$1,245,470 |
D/D |
(10,000) |
14,546 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
VP, Chief Accounting Officer |
• – – |
2020-11-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
600 |
14,546 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
VP, Chief Accounting Officer |
• – – |
2020-11-12 |
4 |
AS |
$176.02 |
$616,070 |
D/D |
(3,500) |
15,146 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
VP, Chief Accounting Officer |
• – – |
2020-11-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,500 |
18,646 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
VP, Chief Accounting Officer |
• – – |
2020-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
17,146 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
VP, Chief Accounting Officer |
• – – |
2020-06-01 |
4 |
AS |
$143.97 |
$287,940 |
D/D |
(2,000) |
15,146 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
VP, Chief Accounting Officer |
• – – |
2020-03-02 |
4 |
AS |
$194.32 |
$388,640 |
D/D |
(2,000) |
15,146 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
VP, Chief Accounting Officer |
• – – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
17,146 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
VP, Chief Accounting Officer |
• – – |
2019-12-02 |
4 |
AS |
$194.24 |
$388,480 |
D/D |
(2,000) |
15,146 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
VP, Chief Accounting Officer |
• – – |
2019-12-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
17,146 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
VP, Chief Accounting Officer |
• – – |
2019-10-28 |
4 |
AS |
$200.00 |
$800,000 |
D/D |
(4,000) |
15,146 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
VP, Chief Accounting Officer |
• – – |
2019-10-28 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
19,146 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
VP, Chief Accounting Officer |
• – – |
2019-10-25 |
4 |
AS |
$190.00 |
$380,000 |
D/D |
(2,000) |
15,146 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
VP, Chief Accounting Officer |
• – – |
2019-10-25 |
4 |
A |
$0.00 |
$0 |
D/D |
5,213 |
17,146 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Principal Accounting Officer |
• – – |
2019-10-18 |
4 |
AS |
$170.00 |
$340,000 |
D/D |
(2,000) |
11,933 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Principal Accounting Officer |
• – – |
2019-10-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
13,933 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Principal Accounting Officer |
• – – |
2019-10-15 |
4 |
AS |
$145.52 |
$2,066,240 |
D/D |
(14,000) |
11,933 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Principal Accounting Officer |
• – – |
2019-10-15 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
25,933 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Principal Accounting Officer |
• – – |
2019-10-14 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
14,933 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Principal Accounting Officer |
• – – |
2019-10-14 |
4 |
AS |
$105.00 |
$315,000 |
D/D |
(3,000) |
11,933 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
